Compare Qbrexza to Other Treatments for Profuse Sweating

November 2018

Rx topical Qbrexza (kyoo-BREK-zah, glycopyrronium) will put new focus on managing hyperhidrosis.

These patients have excessive sweating...usually in the armpits, palms, soles of the feet, or face.

First, rule out med causes...such as venlafaxine, fluoxetine, or tamoxifen. Then suggest a stepwise approach to manage hyperhidrosis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Aspirin Think Twice About Low-Dose Aspirin to Prevent Cardiovascular Disease
E-Cigarettes Talk to Kids About the Harms of E-Cigs and Vaping
Opioids Be Ready for New Strategies to Promote Safe Opioid Use
Osteoporosis Identify Patients at Risk for Fractures Due to Chronic Steroids
Diabetes Meds Evaluate Risks Before Recommending a Flozin
Transdermal Patches Don't Jump to ZTlido Patches for Pain
Pregnancy Expect Med Changes in Pregnant Women With Thyroid Disease
Men's Health Clarify the Role of Antibiotics for Prostatitis
Dermatology Compare Qbrexza to Other Treatments for Profuse Sweating
Dermatology Watch for Xepi, a New Topical Antibiotic for Impetigo
Endocarditis Emphasize Adherence in Endocarditis Patients on Oral Antibiotics
Practice Combat Counterfeit Meds
Communication Personalize Care for Millennial Patients